Wms Partners, LLC Acadia Pharmaceuticals Inc Transaction History
Wms Partners, LLC
- $0
- Q2 2025
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
346Shares Held
165MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$935 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$263 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$196 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$135 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.53B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...